We partner with companies and teams offering solutions to a broad range of national health security threats. DRIVe partnering approaches vary depending on the project. DRIVe has two main solicitations, our EZ BAA for awards under $749K and our BAA Special Instructions for more involved projects.

For additional details about the COVID-19 response please visit the CDC website


To support ongoing U.S. Government COVID-19 medical countermeasure development efforts, BARDA is pleased to open our EZ BAA program and seeks abstract submissions for select COVID-19 medical countermeasures only. Please see solicitation BAA-20-100-SOL-0002 for more information, and apply here.

How to Apply & What to Expect


  • Awards of up to $749K*
  • Emerging Disruptive Ideas
  • Simplified Abstract
  • 30-120 Day Review Target
  1. Review the solicitation on beta.SAM.gov.*
  2. Request an account on the EZ BAA Portal.
  3. Once your account is active, complete the online abstract via the Portal.
  4. BARDA personnel will review your abstract as described in the solicitation.
  5. You'll receive an email notification within 30 days.
  6. *At this time we are only accepting responses related to SARS-CoV-2 programs in the following areas: 4.1D: Diagnostics, 4.3: COVID-19 Vaccines, and 4.4: Advanced Manufacturing Technologies.

*Award amounts may differ depending on award structure and/or availability of funding

DRIVe (Division of Research, Innovation, and Ventures) was established by the Biomedical Advanced Research and Development Authority (BARDA), part of the Assistant Secretary for Preparedness and Response (ASPR), within the United States Department of Health and Human Services (HHS).